Doccla Deepens Virtual Care Footprint Across NHS and Ireland

Doccla – Weekly Recap

Doccla featured prominently this week as it continued to scale its AI-enabled virtual care and remote monitoring solutions across the U.K. and Ireland. The company’s updates underscored growing integration with public health systems, particularly within NHS proactive care strategies and Ireland’s Health Service Executive.

Doccla expanded its virtual ward network to seven sites across all Irish health regions, treating more than 3,000 patients with reported strong satisfaction levels. At St. Vincent’s University Hospital, over 1,600 patients have been managed through Doccla-supported virtual wards, while a Drogheda partnership has supported 128 patients and saved 1,033 bed-days.

In the U.K., Doccla advanced Comfort Tracker, a home-based end-of-life monitoring tool co-developed with NHS clinicians. The solution has already supported over 200 patients across Sussex Community NHS Foundation Trust and East Sussex Healthcare NHS Trust, with plans to reach 1,000 patients in the coming year.

The company highlighted how its remote monitoring model aims to bridge the gap between intensive in-hospital observation and limited post-discharge follow-up. Using clinical-grade wearables, continuous data review and AI tools, Doccla seeks to enable hospital-level care at home and earlier identification of patient deterioration.

Multiple posts emphasized alignment with the NHS “Fit for the Future” 10-year plan and the Neighbourhood Health Framework, positioning AI-enabled virtual care as a key lever for shifting services into community settings. Doccla also outlined guidance for proactive care submissions, stressing the importance of locally defined high-risk cohorts, local financial models and outcomes evidenced from large-scale programs.

To reinforce its data-driven positioning, Doccla launched “Doccla Pulse,” a quarterly briefing aimed at NHS and European health leaders. The newsletter will share patient feedback, evaluated outcomes, pathway spotlights and product updates, targeting a curated audience of decision-makers rather than broad marketing reach.

For the company’s future prospects, these developments suggest growing operational scale, deeper embedding in public health pathways and a strong focus on measurable outcomes such as bed-day reductions. While adoption will still depend on procurement cycles, regulation and funding priorities, this week’s news points to a strengthening competitive position in virtual wards, proactive community care and end-of-life monitoring.